IMD — IMD International Medical Devices SpA Income Statement
0.000.00%
Last trade - 00:00- €26.85m
- €25.57m
- €38.01m
- 23
- 84
- 31
- 40
Annual income statement for IMD International Medical Devices SpA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS |
| Status: | Final | Final | Final |
| Revenue | |||
| Total Revenue | 46.2 | 41.8 | 38 |
| Cost of Revenue | |||
| Gross Profit | 13 | 11.7 | 10.5 |
| Selling / General / Administrative Expenses | |||
| Depreciation and Amortization | |||
| Unusual Expense / Income | |||
| Other Operating Expenses | |||
| Total Operating Expenses | 40.1 | 36.8 | 34.5 |
| Operating Profit | 6.05 | 4.97 | 3.56 |
| Total Net Non Operating Interest Income / Expense | |||
| Net Income Before Taxes | 6.01 | 4.9 | 3.57 |
| Provision for Income Taxes | |||
| Net Income After Taxes | 4.4 | 3.23 | 2.45 |
| Minority Interest | |||
| Net Income Before Extraordinary Items | |||
| Net Income | 4.12 | 2.93 | 2.22 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||
| Income Available to Common Shareholders Including Extraordinary Items | |||
| Diluted Net Income | 4.12 | 2.93 | 2.22 |
| Diluted Weighted Average Shares | |||
| Basic EPS Including Extraordinary Items | |||
| Diluted EPS Including Extraordinary Items | |||
| Diluted EPS Excluding Extraordinary Items | |||
| Normalised Income Before Taxes | |||
| Normalised Income After Taxes | |||
| Normalised Income Available to Common Shareholders | |||
| Diluted Normalised EPS | 0.237 | 0.178 | 0.142 |